Using patented technology, based on surface enhanced resonance Raman scattering, Renishaw Diagnostics Limited has developed the RenDx Multiplex Assay System which provides automated, multiplex, high sensitivity in vitro screening for clinical research into infectious disease.
Renishaw Diagnostics Limited is a subsidiary of Renishaw Group, a leading global supplier of engineering technologies, medical devices and Raman spectroscopy systems. Renishaw's products are used in such diverse applications as machine tool automation, additive manufacturing and medical technologies. Founded in 1973, Renishaw now has 2700 staff in over 30 countries around the world. Renishaw Diagnostics is part of the group's growing focus and expansion into the healthcare sector.